Ayass BioScience, LLC

10/14/2026

A Tiny Cause. A Huge Impact.

Complex diseases rarely develop from a single biological change. They involve interconnected processes across multiple layers—from genetic variation and gene expression to molecular pathways, cellular behavior, and clinical symptoms.

But understanding what changes is not the same as understanding what drives those changes.

BiRAGAS takes a causality-focused approach, integrating multiple layers of biological information to identify potential causal drivers behind complex diseases.

By looking beyond observable effects, BiRAGAS aims to help distinguish underlying disease mechanisms from downstream consequences—bringing us closer to more precise, mechanism-driven research and therapeutic discovery.

Because sometimes, the smallest driver can have the greatest impact.

10/10/2026

DON'T JUST STUDY WHAT FELL. FIND WHAT STARTED IT.

In a chain reaction, every falling domino tells part of the story. But understanding the consequences is not the same as identifying what initiated them.

Disease works in similarly complex ways. Changes in genes, molecular pathways, cells, and tissues can be interconnected, creating a cascade of biological effects.

Traditional analysis can reveal what has changed and which factors are associated with disease. But association alone does not establish causation.

BiRAGAS takes the investigation further.

By integrating multi-omics data with causal inference approaches, BiRAGAS helps identify causal drivers and distinguish them from downstream effects.

Because understanding disease progression is important. Understanding what drives it can be even more valuable.

BiRAGAS — From Complexity to Causality.

10/07/2026

Many paths. One causal driver.
BiRAGAS identifies what matters.
From Complexity to Causality.

10/03/2026

Disease is the outcome. Causality reveals what drives it.
Go beyond association.
Identify the biological drivers behind disease progression.

09/27/2026

From RNA to insight.
Transcriptome sequencing reveals the patterns of gene expression hidden within complex biology.
See the signal. Understand the biology.

09/23/2026

Beyond associations. Beyond correlations. Toward causality.
BiRAGAS helps uncover the causal drivers behind disease—turning complex biological signals into insights that can guide discovery.
Find what matters. Focus on cause. Drive cures.

09/20/2026

Every disease leaves clues.
The challenge is connecting them.
BiRAGAS integrates complex biological and clinical data to uncover causal relationships—and reveal what may be driving disease.
From complexity to causality. From clues to cause.

09/17/2026

From complexity to causality.

Biological systems generate countless associations. But association alone doesn’t reveal what actually drives disease.

BiRAGAS moves beyond correlation to identify causal drivers — turning biological complexity into actionable insight.

Find the driver. Change the outcome.
https://ayassbioscience.com/biragas-causal-platform/

09/13/2026

New Research: Selective Thrombin Modulation with AYA1809002

AYA1809002 is a novel Exosite I-targeting DNA aptamer designed for selective, stable, and reversible thrombin modulation.

The study demonstrates potent inhibition of key procoagulant thrombin functions while preserving thrombomodulin-dependent protein C activation. AYA1809002 also showed strong functional stability and rapid, sequence-specific reversal of its anticoagulant activity.

These findings highlight a promising approach to more precisely controlled anticoagulation.

Selective. Stable. Reversible.

Background: Thrombin is a central mediator of coagulation and platelet activation and a key anticoagulant target. Direct thrombin inhibitors broadly suppress thrombin proteolytic activity, potentially disrupting procoagulant and anticoagulant signaling. Exosite-targeting aptamers may enable selectiv...

09/05/2026

Disease biology is complex. The challenge is finding what actually drives it.

BiRAGAS moves beyond association to uncover causal drivers - helping turn biological complexity into actionable insight.

Find the driver. Change the outcome.